Ankit Mahadevia - May 29, 2024 Form 4 Insider Report for Spero Therapeutics, Inc. (SPRO)

Role
Director
Signature
/s/ Satyavrat Shukla, Attorney-in-Fact for Ankit Mahadevia
Stock symbol
SPRO
Transactions as of
May 29, 2024
Transactions value $
$0
Form type
4
Date filed
5/30/2024, 04:25 PM
Previous filing
Feb 5, 2024
Next filing
Aug 29, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPRO Common Stock Award $0 +20K +2.68% $0.00 765K May 29, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest on May 29, 2025, subject to the Reporting Person's continued service through the applicable vesting date.
F2 Amount includes 65,817 shares of common stock held by the Mahadevia-Mehta Family Trust, of which the Reporting Person is a trustee.